Home About Us Technology Product & Services News & Events Contact Us Facebook

Latest Research at VivoBiotech

Over the last 10 or so years VivoBiotech have witnessed unprecedented discovery efforts to develop selective androgen receptor modulators (SARMs) & Peptides which will improve physical function, bone health and density without adversely affecting the prostate or cardiovascular output. SARM development is import to us at vivo, VivoBiotech are continuasly working to undertstand the mechanisms of testosterone and actions both SARMs and Peptides within the humun body.

Here at VivoBiotech we have also been progressing on researchng the psychotropic effects of cannabinoids which are principally mediated by CB1, which is widely distributed throughout the human brain, but it is mainly deployed into the frontal cortex, basal ganglia and cerebellum. CB1 has also been shown to be present in several tissues and organs, including the adipose tissue, the gastrointestinal tract, the spinal cord, adrenal and thyroid glands, liver and other reproductive organs and immune cells. We will continue to work hand in hand with Next Pharmaceuticals who is a subdivisary of our company that specializes in pharmaceutical and medical trails.


News & Updates

2013 - Latest News
Vivo BioSciences� updates read more

December 2012
Vivo BioSciences� technology named
in the top-10 innovations of 2012
by The Scientist magazine. read more

February 2011
Vivo and ITT Labs sign R&D agreement
for developing chemotherapy
toxicity/profiling applications. read more

  Home / About Us / Technology / Products & Services / News & Events / Contact Us
© 2013 All Rights Reserved. Vivo Biosciences, Inc. Office 1+205-930-0001